Skip to content

MIRATI THERAPEUTICS, INC.

CIK 0001576263

← back to feed
Revenue (TTM)
$42.69M
+4,059.2% YoY Q3 Nov 2023
Net Income (TTM)
−$696.96M
−271.1% YoY Q3 Nov 2023
EPS Diluted (TTM)
−$11.80
−17.6% YoY Q3 Nov 2023
Gross Margin
—
Q3 Nov 2023
Operating Margin
-1,732.5%
Q3 Nov 2023
Net Margin
-1,632.7%
Q3 Nov 2023
Free Cash Flow (TTM)
−$522.81M
Q3 Nov 2023
Cash
$258.72M
Q3 Nov 2023
Total Debt
—
Q3 Nov 2023
Shares Outstanding
70.15M sh
Q3 Nov 2023

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings